Home › Macular Degeneration › Illinois
Macular Degeneration clinical trials in Illinois
13 studies for Macular Degeneration are looking for participants at sites in Illinois.
Cities in Illinois
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- University Retina, Lemont
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- University Retina and Macula Associates, P.C., Lemont
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Illinois Retina Associates, Oak Park
- Springfield Clinic, Springfield
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Sep 18, 2026 · NCT07440225A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- University of Illinois at Chicago, Chicago
- Retinal Vitreal Consultants, Chicago
- The University of Chicago, Chicago
- and 3 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Northwestern Medical Group, Chicago
- The University of Chicago Medicine Duchossois Center for Advanced Medicine, Chicago
- Retina Associates, Ltd., Elmhurst
- and 1 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- University Retina and Macula Associates, Oak Forest
RecruitingObservational study
Ages 55 and older · All sexes · Updated Sep 3, 2026 · NCT07144137A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- University Retina & Macula Associates, Lemont
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Illinois Chicago - UI Health, Chicago
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Illinois Retina Associates, Joliet
- University Retina & Macula Associates, P.C., Lemont
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 179, Lemont
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retina Associates, Ltd., Elmhurst
- University Retina and Macula Associates, PC, Oak Forest
- Illinois Retina Associates, Oak Park
- and 1 more
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.